Diagnosing Sjögren’s syndrome involves a combination of blood tests, eye exams, saliva measurements, and sometimes a lip biopsy. There is no single test that confirms it. Instead, doctors use a scoring system that adds up results from five objective tests, and a total score of 4 or higher meets the formal classification criteria. The process often takes years: one clinical study found a median time from first symptoms to diagnosis of 8.5 years, largely because dry eyes and dry mouth overlap with so many other conditions.
The Scoring System Doctors Use
The current standard comes from a 2016 consensus between the American College of Rheumatology and the European League Against Rheumatism. It assigns weighted points to five test results, and you need a combined score of at least 4 to meet the criteria for primary Sjögren’s syndrome.
Two items carry the most weight, at 3 points each: a positive blood test for anti-SSA antibodies, and a lip biopsy showing a specific pattern of immune cell clusters in the salivary glands. Three other tests are worth 1 point each: an eye surface staining score above a set threshold, a tear production test showing very low output, and a saliva flow rate below a minimum volume. This means a positive antibody test alone (3 points) combined with just one abnormal eye or saliva test (1 point) reaches the threshold of 4. A positive biopsy works the same way.
Blood Tests for Autoantibodies
The first step for most patients is a blood panel looking for specific autoantibodies. The most important is anti-SSA (also called anti-Ro), found in 60% to 70% of people with Sjögren’s. A related antibody, anti-SSB (anti-La), appears in 50% to 60% of patients but is less central to the scoring criteria. Your doctor will also typically check antinuclear antibodies (ANA) and rheumatoid factor, which can support the diagnosis even though they aren’t part of the formal point system.
A positive anti-SSA result carries enormous diagnostic weight because it alone accounts for 3 of the 4 points needed. But a negative result does not rule Sjögren’s out. Depending on the population studied, somewhere between 5% and 25% of patients with dryness symptoms are “seronegative,” meaning they lack these typical antibodies. In some European cohorts, seronegative patients made up as many as one-third of referrals. For these patients, a lip biopsy becomes especially important because it’s the only other test that carries 3 points.
Eye Exams for Dryness
An ophthalmologist plays a key role in the workup. Two tests evaluate how dry your eyes actually are.
The Schirmer’s test is the simpler one. A small strip of filter paper is hooked over your lower eyelid, and you sit with your eyes closed for five minutes. The strip absorbs tears, and the doctor measures how many millimeters of the paper got wet. A healthy eye wets more than 15 mm. Anything under 10 mm is considered abnormal, and 5 mm or less, the cutoff used in the Sjögren’s criteria, indicates severe dryness.
Ocular staining is more detailed. The ophthalmologist applies a dye (lissamine green or fluorescein) to the surface of your eye and examines it under a slit lamp. The dye highlights damaged areas on the cornea and the white of the eye that you can’t see or feel on your own. The damage is graded on a numerical scale, and a score of 5 or higher on at least one eye counts toward the Sjögren’s criteria. This test is better at detecting subtle surface damage than the Schirmer’s test, which can be unreliable for milder forms of dry eye.
Measuring Saliva Production
The unstimulated salivary flow test is straightforward but telling. You sit quietly without eating, drinking, or chewing for a set period, and all the saliva you produce is collected into a container. A flow rate of 0.1 mL per minute or less is the diagnostic cutoff. In one study, 52% of Sjögren’s patients fell at or below that threshold, compared to just 8% of age-matched controls. This test is worth 1 point in the scoring system, so it won’t confirm a diagnosis on its own, but it adds objective evidence of gland dysfunction.
The Lip Biopsy
If your blood tests are negative or borderline, your doctor may recommend a minor salivary gland biopsy. This is the most invasive part of the diagnostic workup, but it’s a brief outpatient procedure. A small incision is made on the inside of your lower lip under local anesthesia, and three to five tiny salivary glands are removed for examination under a microscope.
The pathologist looks for clusters of immune cells (called foci) that have infiltrated the gland tissue. A “focus score” of 1 or higher, meaning at least one cluster of 50 or more immune cells per 4 square millimeters of tissue, is the hallmark finding. This result carries the same 3-point weight as a positive anti-SSA blood test. A focus score of exactly 1 may represent an early or mild form of the disease. Higher scores correlate more strongly with other features of Sjögren’s, including positive antibodies, elevated immunoglobulin levels, and worse eye staining results.
The main downside is temporary numbness or tingling in the lower lip, which can last weeks or occasionally longer. Interpreting the biopsy also requires a pathologist with specific expertise in Sjögren’s, since other conditions can cause immune cells to gather in salivary tissue.
Salivary Gland Ultrasound
Ultrasound of the major salivary glands (the parotid and submandibular glands, located near the jaw and under the chin) is gaining traction as a non-invasive alternative. The imaging can reveal structural changes in the gland tissue, including areas of low echogenicity that reflect damage from chronic inflammation. A systematic review and meta-analysis found that salivary gland ultrasound has a pooled sensitivity of 80% and specificity of 90% for Sjögren’s, which is strong enough that some researchers have proposed adding it to the formal criteria.
Studies suggest ultrasound could replace the Schirmer’s test, ocular staining, or saliva flow measurement without reducing the accuracy of the classification system. It cannot, however, substitute for the lip biopsy or anti-SSA testing, since removing either of those significantly weakened diagnostic performance. For now, ultrasound is not part of the official 2016 criteria, but many rheumatologists use it as a supporting tool, particularly when they want to avoid a biopsy in a patient with suggestive symptoms.
Conditions That Must Be Ruled Out
Dry eyes and dry mouth are extremely common complaints, and many causes have nothing to do with Sjögren’s. Before the scoring system is applied, your doctor needs to exclude conditions that can mimic it. The formal exclusion list includes prior head and neck radiation, active hepatitis C, HIV, sarcoidosis, amyloidosis, graft-versus-host disease, and IgG4-related disease (a condition where a specific type of antibody causes organ inflammation and swelling).
Medications are one of the most frequent culprits for dryness symptoms. Antidepressants, antihistamines, and drugs that block certain nerve signals (anticholinergics) can all reduce tear and saliva production substantially. Other conditions on the differential diagnosis list include Hashimoto’s thyroiditis, celiac disease, lupus, scleroderma, rheumatoid arthritis, and Parkinson’s disease. Even simple dehydration or habitual mouth breathing can produce overlapping symptoms. This long list of look-alikes is a major reason diagnosis takes so many years for the average patient.
Which Doctors Are Involved
Because Sjögren’s affects so many parts of the body, the first doctor to hear about your symptoms might be a family physician, a dentist noticing unusual cavities or dry mouth, an ophthalmologist treating persistent dry eyes, or an ENT specialist evaluating swollen salivary glands. Any of these providers might be the one who first suspects Sjögren’s and refers you onward.
A rheumatologist typically coordinates the formal diagnostic workup, ordering the blood panels and arranging the biopsy if needed. The lip biopsy itself may be performed by the rheumatologist, an oral surgeon, or an ENT specialist. An ophthalmologist handles the Schirmer’s test and ocular staining. Ongoing management usually involves this same team working together, since the disease affects the eyes, mouth, joints, and sometimes internal organs simultaneously.